Sp1293
FROM DIAGNOSIS TO MANAGEMENT IN EOSINOPHILIC ESOPHAGITIS: THE CLINICAL CONSEQUENCES OF A CHRONIC, PROGRESSIVE DISEASE
Date
May 20, 2024
Presenter
Tracks
Related Products
DUPILUMAB IS EFFICACIOUS IN EOSINOPHILIC ESOPHAGITIS REGARDLESS OF PRIOR USE OR PRIOR INADEQUATE RESPONSE, INTOLERANCE, OR CONTRAINDICATION TO SWALLOWED TOPICAL CORTICOSTEROIDS: RESULTS FROM PART C OF THE LIBERTY-EOE-TREET STUDY
BACKGROUND: Gut dysbiosis is associated with persistent multi-system symptoms following SARS-CoV-2 infection, or post-acute COVID-19 syndrome (PACS). We performed a randomised controlled trial to assess the effects of gut microbiome modulation on alleviation of PACS symptoms…
EOSINOPHILIC ESOPHAGITIS: DISCOVER A TREATMENT OPTION FOR YOUR PATIENTS
Take an afternoon break with us to learn about a treatment option for your appropriate patient with eosinophilic esophagitis…
